Argenica Therapeutics Ltd has released a press release.
Argenica Receives $3.97m R&D Tax Incentive Cash Rebate
Earlier from Argenica Therapeutics
- Half Yearly Report and Accounts
- Successful Applicaton for EMA Paediatric Waiver
- Quarterly Activities/Appendix 4C Cash Flow Report
- Brainomix AI Technology Reveals Efficacy of Novel Neuroprotective Drug Candidate in Severe Acute Ischemic Stroke Patients